The inclusion criteria will be:  patients with clinical signs and symptoms of COVID-19; and patients over 18 years and below 60 years of age.  The exclusion criteria will be:  participate in another clinical intervention study; you have a disease or other medical condition that prevents you from using the medications for this intervention; patient incapable of ingesting, retaining and absorbing the intervention medications; and (d) is mentally disabled.